Paid Clinical Trials Ontario
Discover 2,461 paid clinical trials in Ontario. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Clinical Trial of Nabilone for Aggression in Adults with Intellectual and Developmental DisabilitiesClinical Trial of Nabilone for Aggression in Adults with Intellectual and Developmental Disabilities
Sponsor:
Hsiang-Yuan Lin
Location:
Code:
NCT05273320
Conditions
Intellectual Disability
Developmental Disability
Aggression
Behavior Problem
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
Nabilone
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135), Daratumumab, Lenalidomide or Elranatamab and Lenalidomide Compared With Daratumumab, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for TransplantA Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135), Daratumumab, Lenalidomide or Elranatamab and Lenalidomide Compared With Daratumumab, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Sponsor:
Pfizer
Location:
Code:
NCT05623020
Conditions
Multiple Myeloma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Elranatamab
Daratumumab
Lenalidomide
Dexamethasone
Advance Care Planning at London Health Sciences CentreAdvance Care Planning at London Health Sciences Centre
Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Location:
Code:
NCT03297320
Conditions
Advance Care Planning
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
In-depth conversation about Goals of Care and ACP
A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor TreatmentA Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment
Sponsor:
Regeneron Pharmaceuticals
Location:
Code:
NCT05133531
Conditions
Paroxysmal Nocturnal Hemoglobinuria
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ravulizumab
Pozelimab
Cemdisiran
Eculizumab
Probiotic Visbiome for Inflammation and Translocation in HIV IIProbiotic Visbiome for Inflammation and Translocation in HIV II
Sponsor:
University Health Network, Toronto
Location:
Code:
NCT02441231
Conditions
HIV-1 Infection
Eligibility Criteria
Sex: Male
Age: 19+
Healthy Volunteers: Not accepted
Interventions
Visbiome
Placebo
Ribavirin to Enhance Hepatitis B Virus Nucleotide Analog Antiviral ActivityRibavirin to Enhance Hepatitis B Virus Nucleotide Analog Antiviral Activity
Sponsor:
Ottawa Hospital Research Institute
Location:
Code:
NCT03759782
Conditions
Hepatitis B, Chronic
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ribavirin
Tenofovir
Prehabilitation in Elective Colorectal Resection: A Pilot Study (Prehab)Prehabilitation in Elective Colorectal Resection: A Pilot Study (Prehab)
Sponsor:
McMaster University
Location:
Code:
NCT02531620
Conditions
Colorectal Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Physiatry Assessment
Routine Care
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Sponsor:
Takeda
Location:
Code:
NCT04779320
Conditions
Crohn's Disease (CD)
Eligibility Criteria
Sex: All
Age: 2 - 17
Healthy Volunteers: Not accepted
Interventions
Vedolizumab IV
Decision Making in Multiple Sclerosis Care Under UncertaintyDecision Making in Multiple Sclerosis Care Under Uncertainty
Sponsor:
Unity Health Toronto
Location:
Code:
NCT04035720
Conditions
Multiple Sclerosis
Eligibility Criteria
Sex: All
Age: 23 - 70+
Healthy Volunteers: Not accepted
Interventions
Quantitative risk
Sentinel lympH Node Biopsy With Indocyanine Green in Breast Cancer After NEoadjuvant Chemotherapy (SHINE)Sentinel lympH Node Biopsy With Indocyanine Green in Breast Cancer After NEoadjuvant Chemotherapy (SHINE)
Sponsor:
University Health Network, Toronto
Location:
Code:
NCT06085274
Conditions
Breast Cancer
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
ICG guided sentinel lymph node biopsy